Uncategorized
OCT useful in management of DME
Nearly 30.26 million Americans have type 1 or type 2 diabetes, and of those, 4.2 million adults aged 40 and older, or 29%, have diabetic retinopathy. An estimated 11% of all diabetic patients have diabetic macular edema, and 1% to 3% of those have vision loss. These alarming statistics have propelled research and fueled demand for better treatment options. As a result, we have experienced a significant paradigm shift away from laser therapy as the first line of treatment and moved toward the realm of pharmacological therapy, including intravitreal anti-VEGF (Read more...)